Active studies related to heart disease or diabetes
If you have heart disease and/or diabetes, you may be eligible for one of the following research studies.
CLEAR Outcomes
A multicenter study to assess the effects of bempedoic acid on the occurrence of major cardiovascular events in patients with, or at high risk for, cardiovascular disease who are statin-intolerant.
Active studies related to congestive heart failure
If you have been diagnosed with congestive heart failure and have known or unknown evidence of iron deficiency, you may be eligible for:
HEART-FID
This study investigates the efficacy and safety of injectable iron, or ferric carboxymaltose, as a treatment for heart failure with iron deficiency
CONNECT-HF
This heart failure clinical study focuses on care optimization through patient and hospital engagement.
Active studies in follow up (no longer recruiting)
Dal-GenE trial
This is a clinical research study evaluating the effects of an investigational drug on reducing the risk of future cardiac/heart events.
Clear Harmony OLE
This is a randomized, double-blind, placebo-controlled, multicenter long-term safety and tolerability study of ETC-1002 in patients with hyperlipidemia at high cardiovascular risk who are not adequately controlled by their lipid-modifying therapy.
Registries in follow-up (no longer recruiting)
- None at this time
Completed studies (no longer recruiting or in follow-up)
- ACCELERATE
- ARTEMIS
- Cardiovascular Inflammation Reduction Trial (CIRT)
- Clear Harmony
- Clear Wisdom
- EUCLID
- REVEAL
- RE-DUAL PCI
- THEMIS